News & Updates

Show Multimedia Only
Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer

Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer

27 Apr 2022

In patients with high-risk or unfavourable nonmetastatic prostate cancer (nmPC) receiving local definite therapy, the intensification of systemic therapy using chemotherapy or an androgen receptor signaling inhibitor (ARSI), in combination with androgen deprivation therapy (ADT), leads to better oncologic survival measures, reports a recent meta-analysis.

Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer

27 Apr 2022
Intensive urate lowering of little benefit to patients with erosive gout

Intensive urate lowering of little benefit to patients with erosive gout

27 Apr 2022
Asivatrep cream safe, effective for atopic dermatitis

Asivatrep cream safe, effective for atopic dermatitis

26 Apr 2022